Telehealth Treatment

Allergy Treatment

Fast relief for seasonal and year-round allergies. Prescription antihistamines, nasal steroids, and montelukast — delivered to your pharmacy same day.

Board-Certified HIPAA-Compliant Same-Day Available DE · MD · WA

Book a Same-Day Visit →

What Is Allergic Rhinitis?

Allergic rhinitis is an IgE-mediated inflammatory condition of the nasal mucosa triggered by exposure to specific allergens such as pollen, dust mites, pet dander, mold spores, and cockroach allergens. It affects an estimated 10–30% of the global population, making it one of the most prevalent chronic conditions in the United States. According to the American College of Allergy, Asthma and Immunology (ACAAI), approximately 60 million Americans are affected annually, with significant economic burden from missed workdays, impaired sleep, and reduced quality of life. Allergic rhinitis is classified as seasonal (triggered by outdoor allergens such as tree, grass, and weed pollens), perennial (triggered year-round by indoor allergens), or mixed.

Spring flowers and pollen — seasonal allergy triggers and treatment

The underlying immunopathology involves sensitization — initial allergen exposure stimulates B-lymphocytes to produce IgE antibodies, which bind to mast cells and basophils in the nasal mucosa. Upon subsequent allergen exposure, cross-linking of IgE triggers mast cell degranulation and release of histamine, leukotrienes, prostaglandins, and cytokines. This early-phase reaction occurs within minutes and produces sneezing, rhinorrhea, and itching. A late-phase reaction 4–8 hours later, driven by eosinophil infiltration, causes nasal congestion and mucosal hyperresponsiveness. Allergic rhinitis is strongly associated with asthma (the "unified airway" concept), with 40% of patients having comorbid asthma, and vice versa. It is also associated with allergic conjunctivitis, chronic sinusitis, and obstructive sleep apnea.

Telehealth is an excellent fit for allergic rhinitis evaluation and management. At Innocre Telehealth, your board-certified provider evaluates patients in Maryland, Washington, and Delaware using a thorough history of symptom patterns, triggers, living environment, and prior treatment response. Most patients with clear allergic symptoms do not require in-person allergy testing before initiating pharmacotherapy. your provider prescribes evidence-based first-line treatments in accordance with Joint Task Force on Practice Parameters (JTFPP) and ACAAI guidelines, with same-day e-prescriptions sent to your pharmacy.

Common Symptoms

Sneezing — often in rapid bursts

A hallmark early-phase allergic response

Clear, watery rhinorrhea

Profuse runny nose, typically thin and colorless

Nasal congestion & obstruction

Late-phase reaction; often worst in the morning

Itchy nose, eyes & throat (pruritus)

Histamine-mediated itching is highly characteristic

Red, watery eyes (allergic conjunctivitis)

Frequently accompanies nasal symptoms

Post-nasal drip

Mucus draining down the throat, causing chronic cough

Fatigue & impaired concentration

Sleep disruption from nasal obstruction; "brain fog" from antihistamine sedation

Dark circles under the eyes ("allergic shiners")

Periorbital venous congestion from chronic nasal obstruction

How Innocre Treats Allergies Online

Per ACAAI and JTFPP guidelines, intranasal corticosteroids (INCs) are the single most effective pharmacologic treatment for allergic rhinitis and are considered first-line therapy for moderate-to-severe or persistent symptoms. your board-certified provider prescribes INCs including fluticasone propionate (Flonase), mometasone furoate (Nasonex), and budesonide — agents with excellent local anti-inflammatory efficacy and minimal systemic bioavailability. For patients with predominantly histamine-driven symptoms (sneezing, rhinorrhea, itch), second-generation oral antihistamines are preferred due to their favorable side-effect profiles: cetirizine (Zyrtec, 10 mg daily), loratadine (Claritin, 10 mg daily), and fexofenadine (Allegra, 180 mg daily) are all highly effective and non-sedating. First-generation antihistamines (diphenhydramine, chlorpheniramine) are used cautiously due to sedation and anticholinergic effects.

Montelukast (Singulair), a leukotriene receptor antagonist, is an additional option particularly useful for patients with comorbid asthma or exercise-induced bronchoconstriction alongside allergic rhinitis. However, the FDA has issued a black-box warning regarding neuropsychiatric adverse effects including mood changes and suicidal ideation — your provider discusses this risk-benefit profile with each patient individually before prescribing. For patients with significant eye symptoms, prescription or OTC antihistamine/mast-cell stabilizer eye drops (e.g., olopatadine) may be added. Nasal saline irrigation is a highly evidence-based adjunctive measure that reduces allergen load and improves mucosal clearance.

In patients with allergic rhinitis uncontrolled on optimal pharmacotherapy, referral to an allergist for allergen immunotherapy (allergy shots or sublingual tablets/drops) should be considered — your provider can facilitate this referral for patients in Maryland, Washington, and Delaware. Avoidance strategies are also discussed: keeping windows closed during high pollen counts, using HEPA filters, frequent hand-washing after outdoor exposure, and showering before bed to reduce nocturnal allergen exposure. For patients with undiagnosed atopic conditions or suspected food allergies, appropriate referrals and workup are arranged.

⚠️ When to Go to the Emergency Room

Telehealth manages allergic rhinitis well. Seek emergency care immediately if you experience:

• Signs of anaphylaxis: sudden hives, throat tightening, wheezing, or difficulty breathing after allergen exposure — call 911 and use an epinephrine auto-injector (EpiPen) if available
• Throat or tongue swelling (angioedema) causing difficulty swallowing or a feeling that the airway is closing
• Severe wheezing or asthma attack not responding to a rescue inhaler within 20 minutes
• Sudden drop in blood pressure, dizziness, loss of consciousness, or rapid weak pulse following allergen exposure
• Severe facial swelling involving the eyes or lips that is rapidly worsening

Medical Disclaimer: This page is for informational purposes only. It does not constitute medical advice. A licensed provider evaluation is required for diagnosis and treatment.

Allergies — Frequently Asked Questions

According to ACAAI and JTFPP guidelines, intranasal corticosteroids such as fluticasone (Flonase) or mometasone (Nasonex) are the most effective single agents for controlling allergic rhinitis symptoms, including congestion, sneezing, and rhinorrhea. They work best when used consistently, and their full effect may take 1–2 weeks to develop. For faster relief of acute symptoms, a second-generation oral antihistamine such as cetirizine, loratadine, or fexofenadine can be added. Your telehealth provider will tailor treatment to your dominant symptoms and severity.

Montelukast is FDA-approved for allergic rhinitis and asthma, but carries a black-box warning regarding neuropsychiatric side effects including mood changes, depression, nightmares, and in rare cases suicidal thinking. The FDA updated this warning in 2020 following post-marketing safety reviews. Because of this risk, montelukast is generally reserved for patients with comorbid asthma or those who have not responded adequately to antihistamines and nasal corticosteroids. Your provider will discuss the risk-benefit profile in detail before prescribing.

Not necessarily for initial treatment. Most patients with clear, seasonal or perennial allergic symptoms respond well to empiric pharmacotherapy without formal allergy testing. Testing (skin prick testing or specific IgE blood tests) becomes more valuable when the diagnosis is uncertain, when symptoms are severe and uncontrolled, when immunotherapy (allergy shots) is being considered, or when multiple atopic conditions are present. Your provider can guide you on when a referral to an allergist is warranted.

Yes. Allergic conjunctivitis commonly accompanies allergic rhinitis and can be effectively managed with a combination of oral antihistamines (which help both nasal and eye symptoms), prescription antihistamine/mast-cell stabilizer eye drops such as olopatadine (Pataday), and nasal corticosteroids. Cold compresses and avoidance of rubbing the eyes are helpful adjunctive measures. If eye symptoms are severe, one-sided, associated with reduced vision, or not responding to treatment, an ophthalmology referral is appropriate.

Yes. Each region has distinct allergen profiles. Delaware has a humid mid-Atlantic climate with heavy tree pollen in spring, grass pollen in summer, and significant ragweed in fall — plus elevated mold counts year-round due to coastal moisture. Maryland shares a similar four-season pollen calendar dominated by tree pollen in spring, grass in summer, and weed (particularly ragweed) in fall. Washington state has significant grass pollen burdens in eastern regions and elevated mold spore counts in western areas. Moving to a new state or region can trigger new-onset allergies even in previously unaffected individuals. Your provider will factor your geographic location into the treatment plan.

Related Services